These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31467792)

  • 1. Identifying non-muscle-invasive and muscle-invasive bladder cancer based on blood serum surface-enhanced Raman spectroscopy.
    Chen S; Zhu S; Cui X; Xu W; Kong C; Zhang Z; Qian W
    Biomed Opt Express; 2019 Jul; 10(7):3533-3544. PubMed ID: 31467792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study.
    Grossmann NC; Rajwa P; Quhal F; König F; Mostafaei H; Laukhtina E; Mori K; Katayama S; Motlagh RS; Fankhauser CD; Mattei A; Moschini M; Chlosta P; van Rhijn BWG; Teoh JYC; Compérat E; Babjuk M; Abufaraj M; Karakiewicz PI; Shariat SF; Pradere B
    Eur Urol Open Sci; 2022 May; 39():14-21. PubMed ID: 35528782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing.
    Wang F; Dong X; Yang F; Xing N
    Front Genet; 2022; 13():831146. PubMed ID: 35419031
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrative Multi-Omics Analysis for the Determination of Non-Muscle Invasive vs. Muscle Invasive Bladder Cancer: A Pilot Study.
    Yu EY; Zhang H; Fu Y; Chen YT; Tang QY; Liu YX; Zhang YX; Wang SZ; Wesselius A; Li WC; Zeegers MP; Xu B
    Curr Oncol; 2022 Jul; 29(8):5442-5456. PubMed ID: 36005168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy.
    Kayama E; Kikuchi E; Fukumoto K; Shirotake S; Miyazaki Y; Hakozaki K; Kaneko G; Yoshimine S; Tanaka N; Takahiro M; Kanai K; Oyama M; Nakajima Y; Hara S; Monma T; Oya M
    Clin Genitourin Cancer; 2018 Oct; 16(5):e969-e976. PubMed ID: 29778322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of deep learning as a noninvasive tool to differentiate muscle-invasive bladder cancer and non-muscle-invasive bladder cancer with CT.
    Yang Y; Zou X; Wang Y; Ma X
    Eur J Radiol; 2021 Jun; 139():109666. PubMed ID: 33798819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implications of Immunohistochemical Biomarkers in Non-muscle-invasive Blad Cancer and Muscle-invasive Bladder Cancer.
    Boegemann M; Krabbe LM
    Mini Rev Med Chem; 2020; 20(12):1133-1152. PubMed ID: 27173513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.
    Silva TA; Azevedo H
    J Proteomics; 2020 Oct; 229():103951. PubMed ID: 32860965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer.
    Piao XM; Kang HW; Jeong P; Byun YJ; Lee HY; Kim K; Seo SP; Kim WT; Lee JY; Ha YS; Choi YH; Moon SK; Yun SJ; Kim WJ
    Urol Oncol; 2021 Apr; 39(4):237.e21-237.e29. PubMed ID: 33339725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of secondary muscle-invasive bladder cancer.
    Hidas G; Pode D; Shapiro A; Katz R; Appelbaum L; Pizov G; Zorn KC; Landau EH; Duvdevani M; Gofrit ON
    BMC Urol; 2013 May; 13():23. PubMed ID: 23656972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic expression changes between non-muscle-invasive bladder cancer and muscle-invasive bladder cancer.
    Zhao YG; Shi BY; Qian YY; Bai HW; Xiao L; He XY
    Tumori; 2014; 100(6):e273-81. PubMed ID: 25688510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
    Erkoc M; Otunctemur A; Bozkurt M; Can O; Atalay HA; Besiroglu H; Danis E; Degirmentepe RB
    Int J Clin Pract; 2021 Sep; 75(9):e14584. PubMed ID: 34185372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Identification of Nonmuscle-Invasive and Muscle-Invasive Bladder Carcinomas: A Multiparametric MRI Radiomics Analysis.
    Xu X; Zhang X; Tian Q; Wang H; Cui LB; Li S; Tang X; Li B; Dolz J; Ayed IB; Liang Z; Yuan J; Du P; Lu H; Liu Y
    J Magn Reson Imaging; 2019 May; 49(5):1489-1498. PubMed ID: 30252978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-to-mesenchymal transition based diagnostic and prognostic signature markers in non-muscle invasive and muscle invasive bladder cancer patients.
    Singh R; Singh UP; Agrawal V; Garg M
    Mol Biol Rep; 2022 Aug; 49(8):7541-7556. PubMed ID: 35593896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.
    Franco R; Zappavigna S; Gigantino V; Luce A; Cantile M; Cerrone M; Facchini G; Perdonà S; Pignata S; Di Lorenzo G; Chieffi S; Vitale G; De Sio M; Sgambato A; Botti G; Yousif AM; Novellino E; Grieco P; Caraglia M
    J Exp Clin Cancer Res; 2014 Jun; 33(1):48. PubMed ID: 24893613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy.
    Aziz A; Gierth M; Fritsche HM; May M; Otto W; Denzinger S; Wieland WF; Merseburger A; Riedmiller H; Kocot A; Burger M
    Urol Int; 2013; 91(1):97-102. PubMed ID: 23751372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the postoperative prognosis in patients with non-muscle-invasive bladder cancer based on preoperative serum surface-enhanced Raman spectroscopy.
    Zhu R; Jiang Y; Zhou Z; Zhu S; Zhang Z; Chen Z; Chen S; Zhang Z
    Biomed Opt Express; 2022 Aug; 13(8):4204-4221. PubMed ID: 36032588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis.
    Mori K; Yanagisawa T; Katayama S; Laukhtina E; Pradere B; Mostafaei H; Quhal F; Rajwa P; Moschini M; Soria F; D'andrea D; Abufaraj M; Albisinni S; Krajewski W; Fukuokaya W; Miki J; Kimura T; Egawa S; Teoh JY; Shariat SF;
    World J Urol; 2023 Apr; 41(4):909-919. PubMed ID: 35963957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.